cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Profound Medical Corp
1 own
3 watching
Current Price
$12.91
$-0.01
(-0.08%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
268.26M
52-Week High
52-Week High
13.52
52-Week Low
52-Week Low
3.1
Average Volume
Average Volume
0.01M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization268.26M
icon52-Week High13.52
icon52-Week Low3.1
iconAverage Volume0.01M
iconDividend Yield--
iconP/E Ratio--
What does the Profound Medical Corp do?
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
Read More
News & Events about Profound Medical Corp.
Globe Newswire
4 months ago
TORONTO, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (Profound or the Company), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced that updated results from the ...
Globe Newswire
5 months ago
TORONTO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (Profound or the Company), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today provided a U.S. reimbursement ...
Ticker Report
6 months ago
Profound Medical Corp. (NASDAQ:PROF Get Rating) Research analysts at Leede Jones Gab reduced their FY2025 earnings per share (EPS) estimates for shares of Profound Medical in a report released on Monday, August 8th. Leede Jones Gab analyst D. Loe now expects that the company will ...
Ticker Report
6 months ago
Profound Medical (NASDAQ:PROF Get Rating) had its price target decreased by Raymond James from $17.50 to $15.00 in a report published on Monday, BayStreet.CA reports. Raymond James currently has an outperform rating on the stock. Separately, Alliance Global Partners cut their price target on...
Zolmax
6 months ago
Profound Medical (NASDAQ:PROF Get Rating) had its price target lowered by Raymond James from $17.50 to $15.00 in a research report released on Monday morning, BayStreet.CA reports. The brokerage currently has an outperform rating on the stock. Separately, Alliance Global Partners dropped their price...
Frequently Asked Questions
Frequently Asked Questions
What is Profound Medical Corp share price today?
plus_minus_icon
Can Indians buy Profound Medical Corp shares?
plus_minus_icon
How can I buy Profound Medical Corp shares from India?
plus_minus_icon
Can Fractional shares of Profound Medical Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Profound Medical Corp stocks?
plus_minus_icon
What is today’s traded volume of Profound Medical Corp?
plus_minus_icon
What is today’s market capitalisation of Profound Medical Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Profound Medical Corp?
plus_minus_icon
What percentage is Profound Medical Corp down from its 52-Week High?
plus_minus_icon
What percentage is Profound Medical Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$12.91
$-0.01
(-0.08%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00